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Cryptogenic organizing pneumonia (COP), also known as bronchiolitis obliterans organizing
pneumonia (BOOP) is emerging to be a frequently recognized pulmonary illness. The
management and follow-up of the disease progress remains arbitrary. We present a case of
COP where integrated computerized tomography-positron emission tomography (CT-PET)
along with blood inflammatory markers, erythrocyte sedimentation rate (ESR) and
C-reactive protein (CRP) were used to assess the progress of the disease process.
Fluorodeoxyglucose (FDG) activity on CT-PET correlated well with blood inflammatory
markers during remission and relapse. To the best of our knowledge, this is the first case
report to show such correlation. CT-PET may provide valuable information about the
disease activity distinguishing active inflammation from residual fibrosis and thus help to
tailor the steroid therapy.
& 2007 Elsevier Ltd. All rights reserved.Case history
A 71-years-old female with known history of cardiac
arrhythmia, mild bronchial asthma and osteoporosis, wasElsevier Ltd. All rights reserved.
427493; fax: +966 1 4427499.
u.sa (M. Khalid).seen in the clinic with 4 weeks history of dry cough,
generalized body aches and low grade temperature. Physical
examination was normal except bilateral crackles on both
lung bases. Blood tests including complete blood count
(CBC) with differential, blood urea and creatinine, liver and
thyroid functions, collagen vascular disease screening
including anti nuclear antibody (ANA), anti-ds-DNA antibody
and anti-neutorophilic cytoplasmic antibody (ANCA) were
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was raised at 140mm/h and C-reactive protein (CRP) was
130mg/L. Sputum stains and cultures for bacteria, acid fast
bacillus (AFB) and fungi did not reveal any organism. Chest
X-ray showed bilateral nodular lung infiltrates and airspace
disease. Computerized tomography (CT) of chest showed
similar findings (Figure 1).
Patient was treated initially as community acquired
pneumonia with combination of second generation cepha-
losporin and a macrolide, but failed to show any response.
Diagnostic bronchoscopy with bronchoalveolar lavage (BAL)
and transbronchial biopsy was non-conclusive. A video-
assisted thoracoscopic (VATS) biopsy was obtained which
confirmed the histological diagnosis of Cryptogenic organiz-
ing pneumonia (COP).
Patient was started on prednisone at a dose of 1mg/kg
and azithromycin 250mg three times a week as steroid
sparing and anti-inflammatory agent. Patient showed a rapid
clinical response to steroid therapy with sharp decline in the
inflammatory markers including CRP and ESR. After 4 weeks
of therapy, CT-PET was done to assess lung infiltrates and
fluorodeoxyglucose (FDG) activity which showed significantFigure 1 CT ches
Figure 2 CT and CT-PET after 4 weeks of treatment showing markdecrease in the lung infiltrates and minimal FDG activity in
the areas of infiltrates (Figure 2).
After 4 weeks, steroid dose was progressively tapered. At
12 weeks, the patient experienced a relapse in the form of
clinical symptoms and increase in CRP and ESR. A CT-PET at
this time showed markedly increased lung infiltrates and
intense FDG activity in these areas (Figure 3).
Steroid dose was increased to her previous high levels,
following which she improved clinically and showed marked
decline in her blood inflammatory markers and the lung
infiltrates on CT-PET with almost minimal FDG pick up
(Figure 4).
Blood inflammatory markers, CRP and ESR correlated well
with CT-PET finding (Figure 5).
The patient is currently stable under follow up as an out-
patient receiving prednisone and azithromycin.Discussion
COP is emerging to be a significant medical problem since it
was first described by Epler et al.1 in the medical literature.t on diagnosis.
ed resolution of infiltrates and minimal FDG activity on CT-PET.
ARTICLE IN PRESS
Figure 4 CT chest 4 weeks after steroids dose augmentation sowing residual infiltrates with absence of FDG-uptake on CT-PET.
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Figure 5 ESR and CRP levels during diagnosis, remission and
relapse.
M. Khalid et al.26Clinical history and physical examination in COP are usually
non specific. Chest X-ray and CT chest findings may suggest
the diagnosis,2–5 but histological confirmation of thediagnosis is warranted. Diagnosis could be established by
trans-bronchial biopsy,6 percutaneous lung biopsy7 or open
lung biopsy8 but video assisted thoracoscopic biopsy9 is the
most commonly used procedure for histological diagnosis.
CT-PET has been used to depict increased glucose
metabolism in inflammatory and malignant cells. Diseases
such as pneumonia10 bronchiolitis11 radiation pneumonitis12
and sarcoidosis13 frequently show increase FDG activity on
PET scan.
However, its use in the diagnosis or management COP has
never been described to the best of our knowledge. We
hypothesize that since COP is an inflammatory process, it
should also reflect an increase glucose metabolism on PET
scan.
Monitoring the progress of COP by inflammatory mar-
kers14,15 such as white cell count, ESR and CRP has been
recommended, but it remains nonspecific and unreliable.
There are no specific guidelines for tailoring the steroid
therapy for COP, although an arbitrary steroid schedule of
1mg/kg or 60mg/day for 1–3 months, then 40mg/day for 3
months, tapering down to 10–20mg/day for a period of 1
year is usually suggested.16,17
Based on our hypothesis we decided to follow-up the
progress of our patient’s disease with CT-PET not only to
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actual disease activity by FDG uptake on PET scan, which
should distinguish active inflammation from the residual
fibrosis. Blood inflammatory markers ESR and CRP were also
used to assess the disease activity which correlated well
with disease activity as shown on PET scan in our patient.
After steroid therapy, she showed a rapid clinical and
radiological response which was also evident from sharp
decline in her inflammatory markers. Simultaneously,
CT-PET showed significant declined in lung infiltrate with
minimal FDG activity. After tapering the steroids dose her
disease relapsed which became evident by increased
inflammatory markers and an intense FDG activity on PET
scan. Augmentation of steroid therapy at this stage was
followed by decreased levels of inflammatory markers and
marked reductions in lung infiltrates with almost absence of
FDG activity on PET scan. Although inflammatory markers
correlate well with disease activity but CT-PET scan added
significantly to assess the inflammatory activity of lung
infiltrates and helped us in tailoring the steroid therapy in
our patient. We believe that CT-PET can help to indicate
whether pulmonary infiltrates represent active inflamma-
tion or residual fibrosis, thus allowing to adjust steroid
dosage without subjecting the patient to a relapse or the
adverse effects of steroids. CT-PET is still not widely
available, expensive, and may not be easy to repeat
frequently. However, the situation may change in the future.
We also suggest that it may be used in the difficult to
manage cases.
In conclusion, we propose that CT-PET has the potential to
become a valuable monitoring tool in the follow up of COP
patients and may help in the adjustment of steroid therapy.
Further prospective studies on larger number of patients are
needed to verify our observations.
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